Since 1985, when muller invented the polymerase chain reaction (PCR), the way biological scientists work has gradually changed.

The technique, which can obtain a large number of DNA fragments in a short time, has played a huge role in forensic medicine, DNA cloning, genome analysis, and the diagnosis of genetic diseases and infectious diseases.

In the course of nearly three decades, the global PCR industry has experienced a long-term upward development trend, which is accelerating even in the context of the global economic recession, which to some extent proves the optimistic development prospect of this technology.

Innovations in gene amplification techniques in recent years have also demonstrated the dominance of PCR, with molecular diagnostics and the human genome project contributing significantly to the growth of the PCR market.

IQ4I Research&Consult ancyanalysis predicts that the global PCR market will grow at a single-digit compound annual rate and reach $13.4 billion by 2020.

At present, the rapid growth of the medical technology market has increased the demand for early diagnosis of diseases. With the increasing investment in diagnosis, the arrival of the digital PCR era, the imminent expiration of the patent of key PCR technology, and the increasing demand for PCR in gene testing, all these factors have promoted the development of the PCR industry market.

However, strict government control over the technology, lack of sufficient awareness, lack of skilled technicians, development of new generation sequencing technology, and high cost of PCR commercialization have also hindered the development of the PCR market.

In addition, the current demand for portable PCR and thermal circulators has led to a preference for real-time detection rather than sending samples to companies.

The global PCR market can be divided into standard PCR, real-time quantitative PCR, reverse transcription PCR, digital PCR, assembled PCR, multiple PCR, hot-start PCR and others by technology type.

Among them, real-time quantitative PCR occupies the largest market share in 2013 and will reach 5.65 billion by 2020.

In addition, digital PCR is expected to grow at a compound annual growth rate of 12.2% in the future.

Among PCR products, reagents and consumables accounted for the largest market share in 2013, while PCR related services grew steadily at the highest growth rate.

IQ4I's global market report on PCR includes clinical diagnostic applications of PCR (communicable and non-communicable diseases) and industrial applications, including agricultural biotechnology applications, scientific research applications, and more.

Industrial applications account for the largest share of the market and will grow at a single-digit compound annual rate until 2020.

The clinical use of PCR is expected to grow at a double-digit compound annual growth rate of up to 10.2% over time.

Pharmaceutical and biotechnology companies and contract research institutions account for the bulk of PCR end-user populations, but hospitals and laboratories are expected to grow at double-digit cagr rates for some time to come.

Developed regions such as North America controlled the largest market share in 2013 and are expected to reach $5.7 billion by 2020.

The company's investment in medical infrastructure and adequate government financial support will inject new vitality into this market.

However, with increased health awareness, rapid economic growth, and increased disposable income, the asia-pacific PCR market share is expected to grow rapidly at a compound annual growth rate of 12.3% in the future.

In the future, large-scale mergers and acquisitions, cooperation, joint ventures, new product listing will become the main form of market development.